Weekly Recap | Gilead Sciences -4.82%, most brokers rate it buyWeekly Review·Sep 12 at 08:16 AMGILD+1.45%
Weekly Recap | Vertex Pharma -5.62%, low-volume pullback lags the S&P 500Weekly Review·Sep 12 at 07:06 AMVRTX-0.02%
Weekly Recap | Revolution Medicines -2.98%, consensus target above spotWeekly Review·Sep 12 at 06:40 AMRVMD-0.28%
Weekly Recap | Illumina -5.39%, insider selling fuels valuation debateWeekly Review·Sep 12 at 06:07 AMILMN+6.07%
Weekly Recap | Alnylam Pharma -6.55%, consensus target above spotWeekly Review·Sep 12 at 05:55 AMALNY+1.31%
Weekly Recap | IBB.US +1.42%, most brokers rate it buyWeekly Review·Sep 5 at 09:03 AMIBB+2.01%BIB+3.58%
Weekly Recap | IBB.US -2.16%, underperforming the S&P 500Weekly Review·Aug 29 at 07:08 AMIBB+2.01%BIB+3.58%
